ClinicalTrials.gg
RecruitingNCT06709898SWIFTUpdated Mar 13, 2025

Stroke in Working Age and Job Accommodation in Facilitating Transition Back to Work

An interventional study of Cognitive job accommodation in Stroke, Ischemic, Cognitive Impairment and Fatigability Post Stroke, sponsored by Finnish Institute of Occupational Health. Recruiting at 1 site in Finland. Open to participants aged 18 Years to 68 Years. Per ClinicalTrials.gov, last updated 2025-03-13.

Sponsored by Finnish Institute of Occupational Health · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started Jan 2025; still recruiting 1 year 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years to 68 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 38 studies in Ischemic Stroke with a site in Finland — 6 open to participants now, 10 under way, 1 of them phase 3. Ischemic Stroke · Finland.

Planned enrollment
26th of 30
100 · median 495
Started
2025
with 1 other
No phase
8 of 38
2 open now
Registered
37th of 38
by date

Among the 38 studies in Ischemic Stroke with a site in Finland, this one is the 26th largest by planned enrollment of the 30 interventional ones that give a count, is one of 2 that started in 2025, is one of 8 with no phase, and was the 37th registered.

Ischemic Stroke

2,629 studies on the registry are indexed under Ischemic Stroke; 983 are open to participants now.

Browse Ischemic Stroke studies →

Open to participants now

6 of the 38 studies in Ischemic Stroke with a site in Finland are open now. Recruiting first, the newest first:

All 6 open studies →

A study can be open while its sites in Finland have not opened yet or have stopped. Only those recruiting at a site in Finland →

Who these studies take

Of the 668 Ischemic Stroke studies recruiting now, 403 (60%) set no upper age limit and 62 (9%) stop at 75 or younger; 27 take children under 18; 41 take healthy volunteers.

This study: 18 Years to 68 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 38 studies in Ischemic Stroke with a site in Finland, or all of them as a file.
02

Study summary

The aim of this randomized controlled trial (RCT) is to investigate whether cognitive job accommodation intervention enhances return to work, work ability and performance after ischemic stroke in working-age population. The main questions are:

  • Does the cognitive job accommodation intervention affect absenteeism and presenteeism after stroke?
  • Does the intervention affect work ability and perceived cognitive and emotional difficulties at work?
  • Does the intervention decrease mental strain, fatigue and negative mood symptoms after return to work?
  • Does the intervention affect life satisfaction among the stroke patients returning to work?

Researchers will compare the intervention group to a control group returning to work after stroke with current healthcare practices and work procedures.

Participants:

  • At baseline, 6 and 12 month follow-up web-based questionnaires and cognitive tests are administered.
  • At 3 month follow-up participants fill in Brain Work Questionnaire (BWQ) that measures cognitive demands and difficulties at work.
Read the detailed description

Introduction: Strokes are one of the most significant conditions affecting cognition among working-age adults. Incidence of stroke increases in older age and due to the lengthening of working careers, more people are experiencing strokes while still employed. Additionally, the incidence of strokes among younger workers has increased over recent decades. In Finland, 2000 - 3000 work-aged persons suffer a stroke annually. The majority experiences cognitive or emotional symptoms post-stroke, and for about half of them, these symptoms become long-lasting or permanent. The cognitive demands of modern work have steadily increased, and the severity of cognitive symptoms has been shown to strongly predict the likelihood of returning to work after a stroke. While job accommodation has been shown to be an effective way to support return to work after many illnesses, there is limited research on its benefits following a stroke. Furthermore, there is lack of research on cognitive job accommodation, despite health professionals finding it particularly challenging.

Aims: To evaluate the effect of job accommodations after stroke on various work and health related outcomes. In addition, information about working-aged stroke patients returning to work and the practices of job accommodation is provided. In the future these results can potentially be applied also to other conditions affecting cognition.

Participants and methods: This study will recruit 18-68 year old stroke patients who are returning to work (n ≈ 100). Participants will be randomized into either a job accommodation intervention group or a control group. The study will assess the benefits of cognitive job accommodation in terms of absenteeism, presenteeism, work modifications, perceived work ability, health indicators and cognitive and emotional symptoms. Participants will be followed through web-based surveys and novel cognitive tests over a 12-month period. The study will adopt a multidisciplinary approach (ergonomics, occupational psychology, neuropsychology, and medicine) and will be based on the International Classification of Functioning, Disability, and Health (ICF) model. Cognitive job accommodation will utilize an established model, a design form, and an instructional video.

Collaborators and target organizations: The research will be conducted in collaboration with the Helsinki University Hospital Neurocenter and the Finnish Institute of Occupational Health. In addition to these organizations the study is funded by the Finnish Work Environment Fund. The target organizations include occupational health services and workplaces of stroke survivors.

Utilization of Results: The methods developed in this study can be used in future collaborations between workplaces, occupational health services, and specialized healthcare. The findings can also be applied to other conditions that cause cognitive difficulties and require job accommodation.

03

Conditions studied

  • Stroke, Ischemic
  • Cognitive Impairment
  • Fatigability Post Stroke
  • Mood Disturbances

Keywords

  • Stroke
  • Cognitive impairment
  • Return to work
  • Job accommodation
  • Work ability
  • Neuropsychology
04

Who can participate

Ages eligible
18 Years to 68 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Ischemic stroke occurred within 12 month
  • At least mild cognitive, emotional and/or state alertness symptoms detected in neuropsychological assessment in subacute phase
  • Employed when the stroke occurred and has workplace where to return
  • Occupational health services (OHS) available
  • Participant has agreed that clinical neuropsychologist and researcher can participate to OHS consultation regarding the job accommodation
  • Adequate Finnish language ability to the questionnaires and cognitive tests

Exclusion criteria

Exclusion Criteria:

  • Work status - professional driver or some other safety critical occupation where even mild cognitive impairments restrict return to work
  • Former neurological or psychiatric disorder or developmental disability affecting significantly cognition
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Cognitive job accommodation

    * In intervention neuropsychological information will be individually processed and transferred systematically from the neurological unit to occupational health service (OHS) to help design the individually tailored work modifications. * Information of the job accommodation will be given to employers. * Cognitive job accommodation is carried out at the workplace in cooperation between the employer, employee and OHS. * Feedback of the cognitively challenging work traits will be given to participants after returning to work.

    Other: Cognitive job accommodation

  • No intervention
    Reference group

    Employees return to work according to standard health care and workplace procedures.

Interventions

  • OtherCognitive job accommodation

    Job accommodation focused on the cognitive aspects at work

06

What researchers measure

Primary outcomes

  1. Absenteeism and presenteeism

    Absenteeism and presenteeism are evaluated with World Health Organization's Health and Work Performance Questionnaire (HPQ) using both absolute and relative measures. Absolute absenteeism: hours in 4 week (higher value indicates worse outcome). Absolute presenteeism: single question measure of own job performance (score 0-10) analyzed according to the HPQ instructions (higher value indicates better outcome). Relative absenteeism: working hours in 4 week / expected working hours in 4 week. Relative presenteeism: evaluation of own job performance (score 0-10) / evaluation of most other workers job performance (score 0-10). This score is restricted to the range of 0.25 to 2.0 according to HPQ instructions. In both relative scores higher values indicate better outcome.

    Time frame: 6 and 12 months

  2. Work ability

    Estimate of the current work ability measured with single question (score range 0-10, higher score indicate better outcome) from Work Ability Index. Estimate of future work ability measured with single question (categorical variable: yes, no, maybe) from Work Ability Index.

    Time frame: 6 and 12 months

Secondary outcomes

  1. Perceived success in returning to work

    Subjectively evaluated success in returning to work. Single item question with 5 point Likert scale (5= very good; 1= very bad).

    Time frame: 6 and 12 months

  2. Cognitive demands of work and related difficulties

    Frequency of different cognitive demands at work and related perceived difficulties measured with Brain Work Questionnaire. Frequency values are reported as averaged occurrence/week (lower values indicate better outcome), and related difficulties in ordinal response variable (0=no difficulties, 1=sometimes difficult, 2=often difficult). Higher value indicates worse outcome.

    Time frame: 3 and 12 months

  3. Cognitive symptoms at work

    Cognitive symptoms at work measured with The Cognitive Function at Work Questionnaire total score (score range 0-58: higher value indicates worse outcome)

    Time frame: 6 and 12 months

  4. Stress

    Estimates of perceived stress. General stress measured with single item stress question (score range 1-5, lower value indicates better outcome). Theme specific stress (at home, work and financial). Ordinal 4 point response scales. Questions from INTERSTROKE study.

    Time frame: 6 and 12 months

  5. Sick leave days

    Number of days on sick leave after returning to work. Higher value indicates worse outcome.

    Time frame: 6 and 12 months

  6. Insomnia symptoms

    Frequency of insomnia symptoms measured with single item question with ordinal 5 point scale (5=Every night or nearly every night; 1=never). Higher value indicates worse outcome.

    Time frame: 6 and 12 months

  7. Fatigue symptoms

    Fatigue symptoms measured with Fatigue Assessment Scale (FAS). Total score range 10-50. Higher score indicates worse outcome.

    Time frame: 6 and 12 months

  8. Stroke related life satisfaction

    Perceived life satisfaction based on the Young Stroke Questionnaire (total score 0-100; where higher score indicates better outcome)

    Time frame: 6 and 12 months

  9. Mental job strain

    Perceived mental job strain. Single item question with ordinal 1-5 point response scale (1=not at all; 5 very much). Higher value indicates worse outcome.

    Time frame: 6 and 12 months

  10. Perceived cognitive and emotional difficulties in general

    Perceived cognitive and emotional difficulties in general measured with Check List for Cognitive and Emotional Consequences. Likert scale questions 0-2. Higher values indicate worse outcome.

    Time frame: 6 and 12 months

  11. Modified Rankin scale

    The Modified Rankin Scale (mRS) measures degree of disability/dependence after a stroke. The mRS is a 6 point disability scale with possible scores ranging from 0 to 5. Higher score indicates worse outcome.

    Time frame: 12 months from the stroke

  12. Benefit of the job accommodations

    Perceived benefit of the carried out job accommodations. Single item question with 5 point Likert scale (5=very much; 1=very little). Higher value indicates better outcome.

    Time frame: 6 and 12 months

  13. Job burnout symptoms

    Job burnout symptoms measured with Burnout Assessment Tool (BAT) 4-item version. Averaged sum score: range 1-5. Higher score indicates worse outcome.

    Time frame: 6 and 12 months

  14. Depression symptoms

    Depression symptoms measured with Patient health Questionnaire 9 question version (PHQ-9). Total score range 0-27. Higher score indicates worse outcome.

    Time frame: 6 and 12 months

  15. General life satisfaction

    Perceived general life satisfaction measured with single item question with 5 point Likert scale (5=very satisfied; 1=very dissatisfied). Higher score indicates better outcome.

    Time frame: 6 and 12 months

  16. Daily function ability

    Perceived daily ability to function measured with single item question (score range 0-10). Higher score indicates better outcome.

    Time frame: 6 and 12 months

  17. Amount of job accommodations

    Amount of the actualized job accommodations measured with single item question. Ordinal 4 item scale. (3=A lot , 2=somewhat, 1=a little, 0=not at all). Higher value indicates better outcome.

    Time frame: 6 and 12 months

  18. Work participation

    Monthly work participation percentage (%) as compared to fulltime working. Higher value indicate better outcome.

    Time frame: 6 and 12 months

Other outcomes

  1. Cognitive test performance

    Performance in web-based cognitive tests measuring reaction time, attention, executive functions and verbal memory functions. Applied cognitive tests are Task Switching test and Verbal memory test (modified version of the RAVLT).

    Time frame: 6 and 12 months

  2. Level of social support

    Self-reported level of social support measured with Oslo Social Support Scale 3-item version (OSSS-3). Sum score range 3-14. Higher score represent better outcome.

    Time frame: 6 and 12 months

07

Study locations

1 of 1 sites recruiting
  • Helsinki University Hospital Stroke Unit
    Helsinki, Uusimaa 00029, Finland
    Recruiting
08

References and documents

Individual participant data

Plan to share: No — IPD not shared

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2025 (actual). Primary completion is estimated for Dec 2026, 23 months after the start.

Of 576 non-industry interventional studies with no phase under Ischemic Stroke, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 48. This study's planned 23 months is below that.

Counting every sponsor, half of 656 studies reached it within 27 months; a quarter within 14 and three quarters within 48.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 19, 2024
First posted
Nov 29, 2024
StartActual
Jan 10, 2025
Primary completionEst.
Dec 31, 2026
CompletionEst.
Jun 30, 2027
Last update
Mar 13, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 13, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06709898
Lead sponsor
Finnish Institute of Occupational Health
Collaborators
Helsinki University Central Hospital, Finnish Work Environment Fund
Responsible party
Sponsor
First posted
Nov 29, 2024
Start date
Jan 10, 2025
Primary completion
Dec 31, 2026 (estimated)
Completion
Jun 30, 2027 (estimated)
Last update
Mar 13, 2025

Study contacts

Teemu I Paajanen, Dr
Contact
teemu.paajanen@ttl.fi
+358438250389
Nina Nevala, Dr
Contact
nina.nevala@ttl.fi
Teemu I Paajanen, Dr
principal investigator · Finnish Institute of Occupational Health

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion